Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–9 of 9 results
Advanced filters: Author: Matt D. T. Hitchings Clear advanced filters

  • The burden of dengue disease in infants has increased in Brazil over the last 25 years. Here, the authors analyse spatiotemporal heterogeneity in disease incidence to characterise the contribution of changing maternal immunity to infant dengue risk.

    • Matt D. T. Hitchings
    • Angkana T. Huang
    • Derek A. T. Cummings
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-11

  • Here, the authors investigate the effectiveness of the Oxford-AstraZeneca (ChAdOx1) vaccine during extensive Gamma variant SARS-CoV-2 circulation in São Paulo state, Brazil, and find that a two-dose regime is more effective than one dose against mild to severe Covid-19 outcomes in older adults.

    • Matt D. T. Hitchings
    • Otavio T. Ranzani
    • Julio Croda
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-8

  • Antibody mediated immunity to SARS-CoV-2 will affect future transmission and disease severity. This systematic review on antibody response to coronaviruses, including SARS-CoV-2, SARS-CoV, MERS-CoV and endemic coronaviruses provides insights into kinetics, correlates of protection, and association with disease severity.

    • Angkana T. Huang
    • Bernardo Garcia-Carreras
    • Derek A. T. Cummings
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-16

  • Large-scale data on human mobility metrics have been used to gain insights into COVID-19 transmission dynamics, but best practices for use of these datasets have not been established. Here, the authors perform a systematic review to describe the sources of mobility data and methods used for analysis in the early COVID-19 pandemic.

    • Natalya Kostandova
    • Catherine Schluth
    • Amy Wesolowski
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-12

  • SARS-CoV-2 seroprevalence surveys aim to estimate the proportion of the population that has been infected, but their accuracy depends on the characteristics of the test assay used. Here, the authors use statistical models to assess the impact of the use of different assays on estimates of seroprevalence in the United States.

    • Bernardo García-Carreras
    • Matt D. T. Hitchings
    • Derek A. T. Cummings
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-11

  • This study investigates the effectiveness of COVID-19 vaccine boosters following a primary series of CoronaVac vaccination. Using data from Brazil during the Omicron wave, the authors show that boosters provided protection against severe disease, with higher effectiveness from a BNT162b2 than CoronaVac booster.

    • Otavio T. Ranzani
    • Matt D. T. Hitchings
    • Julio Croda
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-10

  • Disentangling the impacts of non-pharmaceutical interventions on COVID-19 transmission is challenging as they have been used in different combinations across time and space. This study shows that, early in the epidemic, school/daycare closures and stopping nursing home visits were associated with the biggest reduction in transmission in the United States.

    • Bingyi Yang
    • Angkana T. Huang
    • Derek A. T. Cummings
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-10

  • Measuring an individual’s level of exposure to COVID-19 is challenging, and it is therefore unclear whether high exposure may impact immunity. Here, the authors investigate this question using data from a correctional facility in Connecticut, USA, by comparing rates of infection in people who share cells, cellblocks, and with no known exposure.

    • Margaret L. Lind
    • Murilo Dorion
    • Albert I. Ko
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-13

  • Mobility data can help to reconstruct infectious disease dynamics and tailor control and elimination measures. We describe three challenges and opportunities to improve our understanding of human mobility for infectious disease research. We call for simulation and modelling, reporting guidelines and investment in data repositories.

    • Natalya Kostandova
    • Ronan Corgel
    • Amy Wesolowski
    Comments & Opinion
    Nature Human Behaviour
    Volume: 9, P: 1309-1312